Thomas M. Shinnick
Affiliations: | Emory University, Atlanta, GA |
Area:
Molecular Biology, Microbiology BiologyGoogle:
"Thomas Shinnick"Children
Sign in to add traineeMolly M. Alligood | grad student | 2002 | Emory |
Courtney E. Maus | grad student | 2005 | Emory |
Mary A. Zaunbrecher | grad student | 2010 | Emory |
Ruth J. Napier | grad student | 2013 | Emory |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lewinsohn DM, Leonard MK, LoBue PA, et al. (2016) Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Denkinger CM, Kik SV, Cirillo DM, et al. (2015) Defining the needs for next generation assays for tuberculosis. The Journal of Infectious Diseases. 211: S29-38 |
Baldwin PR, Reeves AZ, Powell KR, et al. (2015) Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 92: 693-9 |
Shinnick TM, Starks AM, Alexander HL, et al. (2015) Evaluation of the Cepheid Xpert MTB/RIF assay. Expert Review of Molecular Diagnostics. 15: 9-22 |
Reeves AZ, Campbell PJ, Sultana R, et al. (2013) Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7. Antimicrobial Agents and Chemotherapy. 57: 1857-65 |
Datema TA, Oskam L, Engelberts MF, et al. (2012) Global laboratory initiative tool for a stepwise process towards tuberculosis laboratory accreditation. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 16: 704-5 |
Napier RJ, Shinnick TM, Kalman D. (2012) Back to the future: host-targeted chemotherapeutics for drug-resistant TB. Future Microbiology. 7: 431-5 |
Shinnick TM, Gilpin C. (2012) A Risk Assessment-based Approach to Defining Minimum Biosafety Precautions for Tuberculosis Laboratories in Resource-limited Settings Applied Biosafety. 17: 6-10 |
Napier RJ, Rafi W, Cheruvu M, et al. (2011) Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host & Microbe. 10: 475-85 |
Sable SB, Cheruvu M, Nandakumar S, et al. (2011) Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. Plos One. 6: e22718 |